RTI Surgical EV/EBIT
Cos'è EV/EBIT di RTI Surgical?
EV/EBIT di RTI Surgical Holdings, Inc. è N/A
Qual è la definizione di EV/EBIT?
Enterprise value to earnings before interest and taxes (EV/EBIT) is a financial ratio used to measure if a stock is priced appropriately to similar stocks and the market. It is similar to the P/E ratio.
ttm (trailing twelve months)
The EV/EBIT ratio addresses some of the shortcomings of the P/E ratio. Instead of taking market capitalization, the ratio uses enterprise value, as it takes into account the true value of the company. Enterprise value includes both equity and debt. It is calculated as:
Enterprise value = market cap + total debt – cash and cash equivalents
The EV/EBIT ratio is useful in comparing peers within the wider market. A high EV/EBIT ratio indicates that a company’s stock is overvalued. On the opposite, a low EV/EBIT ratio indicates that a company’s stock is undervalued. The lower the ratio, the more financially stable a company should be. However, investors and analyst should use other ratios and information to get a full picture of a company’s financial state and actual value.
EV/EBIT di aziende nel Health Care settore su NASDAQ rispetto a RTI Surgical
Cosa fa RTI Surgical?
RTI Surgical Holdings, Inc. engages in the provision of biologic, metal, and synthetic-based surgical implants. It offers implants in the following categories: extremities, orthobiologics, spine, sports medicine, and surgical specialties. The company was founded in February 1998 and is headquartered in Deerfield, IL.
Aziende con ev/ebit simili a RTI Surgical
- Avesoro Resources ha EV/EBIT di N/A
- Core Gold ha EV/EBIT di N/A
- PFSWEB Inc ha EV/EBIT di N/A
- Premier Explosives ha EV/EBIT di N/A
- Immuron ha EV/EBIT di N/A
- Kazia Therapeutics ha EV/EBIT di N/A
- RTI Surgical ha EV/EBIT di N/A
- Neueon Towers ha EV/EBIT di N/A
- BK Technologies Corp ha EV/EBIT di N/A
- ServiceSource International Inc ha EV/EBIT di N/A
- Unichem Laboratories ha EV/EBIT di N/A
- Amarillo Biosciences ha EV/EBIT di N/A
- Aurinia Pharmaceuticals Inc ha EV/EBIT di N/A